3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
9
Prostate Adenocarcinoma
1
Pain
1
Castration-resistant Prostate Cancer
1
Biochemical Recurrent Prostate Cancer
1
Interventions
enzalutamide
3
Abiraterone Acetate
2
testosterone enanthate
1
pembrolizumab
1
disitamab vedotin
1
abiraterone
1
Radium-223
1
Prednisone
1
Ketoconazole
1
Hydrocortisone
1
Flutamide
1
Calcitriol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Castration-resistant Prostate Cancer
×
Radium-223
×
Clear all
NCT03305224
2021-09-09
CORE-OCU
Osaka City University
Phase 2
Unknown
10 enrolled